Tandem Diabetes Secures Series B Funding

Advised Tandem Diabetes, a manufacturer of durable insulin pumps for individuals with diabetes, in its $13 million Series B funding led by Domain Associates on June 12, 2008, putting the company's pre-money valuation at $21.7 million. TPG and Second Technology Capital Investors also participated in the round.